Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome, Science, vol.300, issue.5624, pp.1394-1399, 2002. ,
DOI : 10.1126/science.1085952
WHO declares Beijing to be free of SARS, The Lancet, vol.361, issue.9376, p.2212, 2003. ,
DOI : 10.1016/S0140-6736(03)13790-7
Association of Human???Leukocyte???Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome, The Journal of Infectious Diseases, vol.190, issue.3, pp.515-518, 2004. ,
DOI : 10.1086/421523
Association of HLA class I with severe acute respiratory syndrome coronavirus infection, BMC Medical Genetics, vol.348, issue.1, p.9, 2003. ,
DOI : 10.1056/NEJMoa030666
ACE1 polymorphism and progression of SARS, Biochemical and Biophysical Research Communications, vol.323, issue.3, pp.1124-1129, 2004. ,
DOI : 10.1016/j.bbrc.2004.08.208
Treatment of SARS with human interferons, The Lancet, vol.362, issue.9380, pp.293-294, 2003. ,
DOI : 10.1016/S0140-6736(03)13973-6
SARS TREATMENT: Interferon Shows Promise in Monkeys, Science, vol.303, issue.5662, pp.1273-1275, 2004. ,
DOI : 10.1126/science.303.5662.1273a
Severe Acute Respiratory Syndrome???Related Coronavirus Is Inhibited by Interferon?????, The Journal of Infectious Diseases, vol.189, issue.7, pp.1164-1167, 2004. ,
DOI : 10.1086/382597
The Human 2',5'-Oligoadenylate Synthetase Family: Interferon-Induced Proteins with Unique Enzymatic Properties, Journal of Interferon <html_ent glyph="@amp;" ascii="&"/> Cytokine Research, vol.19, issue.4, pp.295-308, 1999. ,
DOI : 10.1089/107999099313992
Vesicular stomatitis virus transcription inhibited by purified MxA protein, Virology, vol.206, issue.1, pp.545-554, 1995. ,
DOI : 10.1016/S0042-6822(95)80071-9
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins, J Virol, vol.72, pp.1516-1522, 1998. ,
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections, J Virol, vol.73, pp.6984-6991, 1999. ,
Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection, Journal of Viral Hepatitis, vol.64, issue.3, pp.271-276, 2004. ,
DOI : 10.1056/NEJM200012073432301
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR, Genes and Immunity, vol.4, issue.6, pp.411-419, 2003. ,
DOI : 10.1038/sj.gene.6363984
Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population, Biochemical and Biophysical Research Communications, vol.329, issue.4, pp.1234-1239, 2005. ,
DOI : 10.1016/j.bbrc.2005.02.101
A case-control study on the risk factor s of sever e acute respiratory syndromes among health care workers, Chin J Epidemiol, vol.25, pp.741-744, 2004. ,
Study on the risk factors related to severe acute respiratory syndrome among close contactors in Beijing, Chin J Epidemiol, vol.25, pp.674-676, 2004. ,
Study on the epidemiology and measures for control on severe acute respiratory syndrome in Guangzhou city, Chin J Epidemiol, vol.24, pp.353-3757, 2003. ,
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice, Proceedings of the National Academy of Sciences, vol.8, issue.10, pp.11311-11316, 2002. ,
DOI : 10.1016/0092-8674(86)90493-9
Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein, Immunology and Cell Biology, vol.8, issue.3, pp.230-236, 2003. ,
DOI : 10.1073/pnas.202448899
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences, EMBO J, vol.4, pp.2249-2256, 1985. ,
The Cleavage/Polyadenylation Activity Triggered by a U-rich Motif Sequence Is Differently Required Depending on the Poly(A) Site Location at Either the First or Last 3'-Terminal Exon of the 2'-5' Oligo(A) Synthetase Gene, Journal of Biological Chemistry, vol.277, issue.39, pp.35808-35814, 2002. ,
DOI : 10.1074/jbc.M200540200
The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein, Journal of Clinical Virology, vol.30, issue.3, pp.211-213, 2004. ,
DOI : 10.1016/j.jcv.2003.11.013
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons, Antivir Ther, vol.9, pp.1003-1011, 2004. ,
Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis, Neurology, vol.62, issue.3, pp.457-460, 2004. ,
DOI : 10.1212/01.WNL.0000106940.95749.8E
Genetic Polymorphism of the <i>MxA</i> Gene Promoter and Interferon Responsiveness of Hepatitis C Patients: Revisited by Analyzing Two SNP Sites (???123 and ???88) in vivo and in vitro, Intervirology, vol.44, issue.6, pp.379-382, 2001. ,
DOI : 10.1159/000050075
Differential transcriptional expresi??n of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment, Pharmacogenetics, vol.14, issue.3, pp.189-193, 2004. ,
DOI : 10.1097/00008571-200403000-00007